ITGA6

Chr 2AR

integrin subunit alpha 6

Also known as: CD49f, ITGA6A, ITGA6B, JEB6, VLA-6

The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 6 subunit. This subunit may associate with a beta 1 or beta 4 subunit to form an integrin that interacts with extracellular matrix proteins including members of the laminin family. The alpha 6 beta 4 integrin may promote tumorigenesis, while the alpha 6 beta 1 integrin may negatively regulate erbB2/HER2 signaling. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.531 OMIM phenotype
Clinical SummaryITGA6
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
57 unique Pathogenic / Likely Pathogenic· 263 VUS of 857 total submissions
📖
GeneReview available — ITGA6
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.53LOEUF
pLI 0.000
Z-score 4.56
OE 0.37 (0.270.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.65Z-score
OE missense 0.81 (0.750.87)
463 obs / 574.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.37 (0.270.53)
00.351.4
Missense OE?0.81 (0.750.87)
00.61.4
Synonymous OE?0.92
01.21.6
LoF obs/exp: 23 / 61.6Missense obs/exp: 463 / 574.0Syn Z: 0.95
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedITGA6-related epidermolysis bullosa with pyloric atresiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6648th %ile
GOF
0.6150th %ile
LOF
0.3258th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Literature Evidence

DNHerein, we report a novel heterozygous missense mutation in the ITGB4 gene exerting a dominant negative effect that cosegregates with the EB phenotype in an extended family.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

References

  1. 1.PMID 26817667

ClinVar Variant Classifications

857 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic23
VUS263
Likely Benign406
Benign81
Conflicting23
34
Pathogenic
23
Likely Pathogenic
263
VUS
406
Likely Benign
81
Benign
23
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
28
0
5
1
34
Likely Pathogenic
21
2
0
0
23
VUS
2
214
40
7
263
Likely Benign
1
6
182
217
406
Benign
0
6
71
4
81
Conflicting
23
Total52228298229830

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

21 pathogenic / likely-pathogenic (of 23) ClinVar copy-number / structural variants overlap ITGA6 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ITGA6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →